1. Academic Validation
  2. Mutations of the E-cadherin gene in human gynecologic cancers

Mutations of the E-cadherin gene in human gynecologic cancers

  • Nat Genet. 1994 May;7(1):98-102. doi: 10.1038/ng0594-98.
J I Risinger 1 A Berchuck M F Kohler J Boyd
Affiliations

Affiliation

  • 1 Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Triangle Park, North Carolina 27709.
Abstract

Expression of the E-cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E-cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E-cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wild-type alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E-cadherin as a human tumour suppressor gene.

Figures